Physician profile
Paul Rizk
NPI 1407344526
$12,640.06
in general payments reported to CMS, 2019-2025
8 companies · $4,583 in 2025
The $4,583 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $29.97 · 2022: $1,575 · 2023: $771 · 2024: $5,578 · 2025: $4,583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,750 · Food and Beverage: $1,618 · Travel and Lodging: $517 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,750.00 |
| Food and Beverage | $1,618.16 |
| Travel and Lodging | $517.16 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,020.04 | 2024-2025 | K-15 Pork, Journey II, Or3o Dual Mobility |
| Stryker Corporation | $2,294.84 | 2022-2025 | Stryker Nav3, Orthomap, Gmrs |
| Zimmer Biomet Holdings, INC. | $634.30 | 2024 | Persona, Oxford Partial Knee |
| Boston Scientific Corporation | $230.07 | 2019-2023 | Ams 700 Cxr Rte Kit |
| Orthalign INC | $158.73 | 2024 | Orthalign Plus |
| Onkos Surgical, INC. | $152.09 | 2024 | Eleos Limb Salvage System |
| Axonics, INC. | $121.38 | 2023 | Bulkamid |
| 180 Medical, INC. | $28.61 | 2023 | Gentlecath Glide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Rizk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.